PYY and obesity due to melanocortin 4 receptor deficiency: This group also proposed that endogenous PYY concentration was lower in obese rodents and humans, inversely associated with obesity-related phenotypes [13], and the administration of PYY could effectively reduce food intake and body weight independent of obesity status [1], [13], [14].